Cargando…
MicroRNA-564 inhibits the progression of non-small cell lung cancer via targeting plexin A4
Νon-small cell lung cancer (NSCLC) is the most frequently diagnosed type of cancer, and the most prevalent cause of cancer-associated mortality. The present study aimed to investigate whether microRNA (miR)-564 influences NSCLC progression by regulating NSCLC cell growth and migration, via targeting...
Autores principales: | Ding, Hui, Li, Liangpeng, Gu, Biao, Ni, Yaojun, Chen, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903456/ https://www.ncbi.nlm.nih.gov/pubmed/33732331 http://dx.doi.org/10.3892/etm.2021.9789 |
Ejemplares similares
-
MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1
por: Jiang, Chunming, et al.
Publicado: (2016) -
microRNA-564 inhibits the aggressive phenotypes of papillary thyroid cancer by directly targeting astrocyte-elevated gene-1
por: Song, Zhenzhen, et al.
Publicado: (2019) -
microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction]
Publicado: (2021) -
Downregulation of microRNA-301a inhibited proliferation, migration and invasion of non-small cell lung cancer by directly targeting DLC1
por: Wu, Zhuyu, et al.
Publicado: (2017) -
56.4 Accomplishing Change in This Digital World
por: Krakower, Scott
Publicado: (2022)